Form 4 Tracker
REGENERON PHARMACEUTICALS, INC.
REGN

14 insider filings · Latest: Oct 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 9, 2026Feb 11 9:02 PMArthur F RyanDirector
Sale
100$778.53$77.9K17,803(D)

View →

Feb 9, 2026Feb 9 10:02 PMArthur F. Ryan
Proposed Sale
400$785.51$314.2K—

View →

Feb 9, 2026Feb 9 9:03 PMPitofsky Jason
Proposed Sale
2,036$783.17$1.6M—

View →

Jan 7, 2026Jan 7 5:03 PMBassler Bonnie L
Proposed Sale
1,500$800.00$1.2M—

View →

Nov 20, 2025Nov 20 7:31 PMBassler Bonnie L
Proposed Sale
760$750.00$570.0K—

View →

Nov 7, 2025Nov 7 10:06 PMJason Pitofsky
Proposed Sale
431$651.00$280.6K—

View →

Oct 29, 2025Oct 29 8:36 PMChristine Poon
Proposed Sale
6,500$652.91$4.2M—

View →

Nov 1, 2024Nov 1 8:38 PMMARION E MCCOURT
Proposed Sale
1,000$844.61$844.6K—

View →

Oct 1, 2024Oct 1 8:13 PMMARION E MCCOURT
Proposed Sale
1,000$1,054.06$1.1M—

View →

Sep 3, 2024Sep 3 8:04 PMMARION E MCCOURT
Proposed Sale
1,000$1,178.73$1.2M—

View →

Aug 28, 2024Aug 28 8:35 PMChristopher Fenimore
Proposed Sale
5,680$1,205.21$6.8M—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 13, 2026Oct 15 8:02 PMAndrew J MurphyCo-Chief Scientific Officer
Option Exercise
17,000$381.9217,000(D)

View →

Sep 2, 2026Sep 3 8:47 PMKathryn GuariniDirector
Option Exercise
400$719.371,158(D)

View →

Aug 19, 2026Aug 21 8:01 PMJoseph J LarosaEVP General Counsel and Secret
Option Exercise
12,282$381.9212,283(D)

View →

Aug 18, 2026Aug 20 8:01 PMChristopher R. FenimoreEVP Finance CFO
Option Exercise
6,283$381.926,000(D)

View →

Aug 10, 2026Aug 12 8:16 PMKathryn GuariniDirector
Option Exercise
400$719.371,558(D)

View →

Aug 10, 2026Aug 12 8:14 PMHuda Y ZoghbiDirector
Option Exercise
800$376.690(D)

View →

Feb 19, 2026Feb 23 9:55 PMHuda Y ZoghbiDirector
Option Exercise
1,638$376.69800(D)

View →

Feb 9, 2026Feb 11 9:03 PMJason PitofskySVP Controller
Option Exercise
1,000$492.00905(D)

View →